Evaluation of c-kit protein (CD-117) immunostaining in canine mammary tumors

Authors

  • André Rebelo PANTOJA Universidade da Amazônia (UNAMA)
  • Marina Mariana de Sousa BASTOS Hospital Veterinário da Universidade Federal Rural da Amazônia (UFRA)
  • Carolina Franchi JOÃO Universidade Federal do Pará (UFPA)
  • Mário José Costa CARNEIRO Universidade Federal do Pará (UFPA)
  • Pedro Silva BEZERRA Universidade Federal do Pará (UFPA)

Keywords:

Mammary tumor, CD117, immunohistochemistry, female dogs

Abstract

Mammary neoplasms in dogs have a significant relevance in the veterinary clinical routine and the search for new associated factors in its etiopathogenesis and therapy is necessary to enable the study of new more effective therapies. This study aimed to evaluate the behavior of c-kit expression in benign and malignant canine mammary tumors by immunohistochemistry. The samples were evaluated for intensity staining, percentage of labeled cells, to obtain the final score. For the positive control was used a positive mastocytoma sample for c-kit expression. 32 samples of breast carcinomas and five samples of benign breast tumors were used. All tumors express c-kit, with cytoplasmic pattern. Sixteen carcinomas showed a low score of immunostaining and 16 had high scores. All benign breast tumors had high immunostaining score. Expression of c-kit was greater in tumors compared to benign malignant tumors. The anaplastic carcinomas showed high final score and grade III. suggesting greater expression in this tumor type.

References

AL-DISSI, A.N.; HAINES, D.M.; SINGH, B.; KIDNEY, B.A. Immunohistochemical

expression of vascular endothelial growth factor and vascular endothelial growth factor

receptor-2 in canine simple mammary gland adenocarcinomas. The Canadian Veterinary

Journal, v.5, n.10, 2010.

CASSALI, G.D.; LAVALLE, G.E.; DE NARDI, A.B.; FERREIRA, E.; BERTAGNOLLI,

A.C.; ESTRELA-LIMA, A.; ALESSI, A.C.; DALECK, C.R.; SALGADO, B.S.;

FERNANDES, C.G.; SOBRAL, R.A.; AMORIM, R.L.; GAMBA, C.O.; DAMASCENO,

K.A.; AULER, P.A.; MAGALHÃES, G.M.; SILVA, J.O.; RAPOSO, J.J.; FERREIRA,

A.M.R.; OLIVEIRA, L.O.; MALM, C.; ZUCCARI, D.A.P.C.; TANAKA, N.M.; RIBEIRO,

L.R.; CAMPOS, L.C.; SOUZA, C.M.; LEITE, J.S.; SOARES, L.M.C.; CAVALCANTI,

M.F.; FONTELES, Z.G.C.; SCHUCH, I.D.; PANIAGO, J.; OLIVEIRA, T.S.; TERRA,

E.M.; CASTANHEIRA, T.L.L.; FELIX, A.O.C.; CARVALHO, G.D.; GUIM, T.N.; GUIM,

T.N.; GARRIDO, E.; FERNANDES, S.C.; MAIA, F.C.L.; DAGLI, M.L.Z.; ROCHA, N.S.;

FUKUMASU, H.; GRANDI, F.; MACHADO, J.P.; SILVA, S.M.M.S.; BEZERRI, J.E.;

FREHSE, M.S.; PAES DE ALMEIDA, E.C.; CAMPUS, C.B. Consensus for the diagnosis,

prognosis and treatment of canine mammary tumors. Brazilian Journal of Veterinary

Pathology, v.4, p.153-180, 2014.

INCA (Instituto Nacional do Câncer). Tipos de câncer: mama. Rio de Janeiro: Ministério da

Saúde; 2013. Acesso em 19 de maio de 2015. Disponível em:

http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/mama>. Acesso em 13

de abril de 2016.

KARAYANNOPOULOU, M.; KALDRYMIDOU, E.D.A. Histological grading and

prognosis in dogs with mammary Carcinomas: application of a human grading method.

Journal of Comparative Pathology, v.133, p.246-252, 2005.

LAVALLE, G.E.; BERTAGNOLLI, A.C.; TAVARES, W.L.F.; CASSALI, G.D. COX-2

Expression in Canine Mammary Carcinomas: Correlation with Angiogenesis and Overall

Survival. Veterinary Pathology, v.46, p.1275-1280, 2009.

LONDON, C.A. Tyrosine kinase inhibitors in veterinary medicine. Topic in Companion

Animal Medicine, v.24, p.106-112, 2009.

MARTINI, A.R.A.F.; DAMIANO, R.F.; TOLEDO, M.T.; SANTOS, N.B.;

RODRIGUEIRO, D.A. Expressão de c-kit como fator prognóstico para pacientes com

câncer de mama triplo-negativos. Revista da Faculdade de Ciências Médicas de Sorocaba,

v.16, 2014.

MAFFINI, M.V.; SOTO A.M.; SONNENSCHEIN, C.; PAPADOPOULOS, N.;

THEOHARIDES, T.C. Lackof c-kit receptor promotesmammarytumors in Nnitrosomethylurea-

treated Ws/Ws rats. Cancer Cell International, v.8, p.5, 2008.

MISDORP W.; ELSE R.W.H. Histological classification of mammary tumors of the dog

and the cat. 2a ed., Washington: Armed Forces Institute of Pathology, v.7, n.59, p.18-27,

MUNDIM, F.G.L.; LOGULLO, A.F. Role of the expression of the tyrosine kinase receptor

KIT in invasive ductal carcinomas of the breast. Applied Cancer Research, v.29, n.2, p.50-

, 2009.

POLAT, A. C-kit expression in columnar cell lesions of the breast ac- companied by benign

and malignant breast diseases. Pathology, Research and Practice, v.203, p.765-9, 2007.

REGUERA, M.J.; RABANAL, R.M.; PUIGDEMONT, A.; FERRER, L. Canine mast cell

tumors express stem cell factor receptor. American Journal of Dermathopatology, v.22, p.49-

, 2000.

SALVADOR, R.C.L. Expressão gênica e proteica da cox-2 e c-kit em neoplasias mamárias

de cadelas. 79p. Dissertação apresentada à Faculdade de Ciências Agrárias e Veterinárias –

UNESP, Campus de Jaboticabal, 2014.

Published

2019-12-31

How to Cite

PANTOJA, A. R.; BASTOS, M. M. de S.; JOÃO, C. F.; CARNEIRO, M. J. C.; BEZERRA, P. S. Evaluation of c-kit protein (CD-117) immunostaining in canine mammary tumors. Ciência Animal, [S. l.], v. 29, n. 4, p. 32–38, 2019. Disponível em: https://revistas.uece.br/index.php/cienciaanimal/article/view/9728. Acesso em: 4 jul. 2024.

Issue

Section

Artigos Originais